The increasingly popular class of GLP-1 receptor and GIP dual medications, like tirzepatide, semaglutide, and the newly introduced retatrutide, offer promising improvements in metabolic treatment . While https://semaglutide552690.getblogs.net/76458171/semaglutide-a-detailed-look